Header cover image

Italian (Borsa Italiana) Healthcare Sector Analysis

UpdatedJan 20, 2022
DataAggregated Company Financials
  • 7D-5.3%
  • 3M-11.2%
  • 1Y4.7%
  • YTD-10.3%

Over the last 7 days, the Healthcare industry has dropped 4.7%, driven by a decline by Recordati Industria Chimica e Farmaceutica of 6.8%. This takes the industry's 12 month performance to a gain of 4.1%.

Sector Valuation and Performance

Has the Italian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Thu, 20 Jan 2022€33.2b€6.8b€1.0b23x
Sat, 18 Dec 2021€35.8b€6.8b€1.0b23.3x
Mon, 15 Nov 2021€38.3b€6.7b€997.2m25x
Wed, 13 Oct 2021€34.5b€6.6b€1.0b26.6x
Fri, 10 Sep 2021€38.3b€6.6b€1.0b29.8x
Sun, 08 Aug 2021€35.9b€6.4b€1.0b29.8x
Sat, 01 May 2021€30.6b€6.1b€925.0m23.4x
Tue, 02 Feb 2021€30.8b€5.8b€866.3m24.7x
Fri, 06 Nov 2020€30.4b€5.7b€815.4m33.2x
Mon, 10 Aug 2020€28.7b€5.5b€754.5m32.8x
Sun, 03 May 2020€23.3b€5.5b€736.0m27x
Wed, 05 Feb 2020€21.9b€5.5b€738.1m28.2x
Sat, 09 Nov 2019€20.3b€5.3b€703.2m26x
Fri, 02 Aug 2019€20.9b€5.1b€684.2m25.6x
Mon, 06 May 2019€17.8b€4.9b€668.1m26.4x
Thu, 07 Feb 2019€15.6b€4.6b€633.7m21.1x
PE Ratio


Total Market Cap: €15.6bTotal Earnings: €633.7mTotal Revenue: €4.6b0%0%0%3 Year10 Year

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 27.0x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 17% per year over the last three years, and revenues for these companies have grown 14% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Italian Healthcare sector?

Life Sciences-2.10%
Healthcare Services-4.51%
Medical Equipment-5.28%

Industry PE: Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 26.0x. This is likely because analysts are expecting annual earnings growth of 38%, which is higher than its past year's earnings growth of 3.7% per year. Meanwhile, investors are most pessimistic about the Biotech industry, which is trading below its 3-year average of 23.8x.

Forecasted Growth: Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 64% over the next 5 years. Meanwhile, the Biotech industry is expected to see its earnings decline by 34% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PHIL Philogen€14.504.3%
SHE Shedir Pharma Group€4.643.1%
HI Health Italia€1.495.1%
PRL Pierrel€0.220.9%
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News